Q4'25 Psychedelic Lobbying Update - Psychedelic Alpha

Psychedelic Alpha publishes a quarterly roundup of federal lobbying disclosures tied to psychedelic drug developers and nonprofits. The update frames lobbying filings as a lagging indicator because submissions are not required immediately at quarter end, and points readers to its Psychedelics Federal Lobbying Tracker for the underlying dataset. The bulletin then reviews Q4 2025 lobbying activity with analysis intended for Psychedelic Alpha subscribers, positioned as ongoing monitoring of how advocacy efforts evolve alongside the psychedelics industry and policy landscape.